Run2Cure Domain - POSTPONED
Due to the on-going COVID-19 restrictions in Sydney, we are postponing our charity’s fun run, Run2Cure Domain 2021. We are very disappointed we are unable to hold our main fundraising event in The Domain as planned on 4th September. However, the health and safety of our participants, families, staff and volunteers is paramount as well as respecting the current NSW Government restrictions. We are working with NSW Health and the Royal Botanic Gardens on securing a new date for early 2022, we will provide an update as soon as possible.
Please remain patient while we update our website accordingly and answer any queries.
Take a look at our Run2Cure merchandise range
Get the look and contribute to research toward a cure for the children's cancer neuroblastoma by shopping at our online store.
Support amazing kids like Jazmyn
It’s a shock to learn that children, particularly those with rare
diseases like neuroblastoma, come last in the world of cancer research.
Our Run2Cure Superheroes and their families have shared their stories to help raise awareness of this devastating cancer. Get to know them through our Superhero pages and find out why research is so important.
Be rewarded for raising funds for research into a cure
The recent pandemic has impacted our charity and our neuroblastoma families. Now, more than ever, we need to make sure that we keep funding research into better treatments for this devastating children’s cancer.
Great fundraising prizes are available to those who raise vital funds (starting at only $60 fundraising) for neuroblastoma.
How Run2Cure Domain 2021 is going so far
A step closer to a world where all children diagnosed with neuroblastoma get the chance to grow up.
Run2Cure has grown through the support of our neuroblastoma community from a small fun run in Sydney Park in 2013 to a significant annual community event with over 5000 people from all over Australia, coming together to raise awareness and desperately needed funds for research into a cure for this children’s cancer.